Dedifferentiated Liposarcoma
📧 Sign up to get email alerts when something new happens for Dedifferentiated Liposarcoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-15Clinical Trial Update: Oleclumab and Durvalumab for the Treatment of Recurrent, Refractory, or Metastatic Sarcoma [Phase 2]
Phase 2 clinical trial update of the combination of oleclumab and durvalumab for recurrent, refractory, or metastatic sarcoma, including ang…
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced Sarcoma [Phase 1]
Phase 1 trial evaluating the safety of low-dose pegylated liposomal doxorubicin in combination with peposertib for advanced sarcoma; current…
-
CLINICAL_TRIALS trial_result · 2026-03-05Clinical Trial Update: Nivolumab With and Without Ipilimumab and Radiation Therapy in Treating Patients With Recurrent or Resectable Undifferentiated Pleomorphic Sarcoma or Dedifferentiated Liposarcoma Before Surgery [Phase 2]
This is a Phase 2 clinical trial evaluating nivolumab with or without ipilimumab, plus radiation therapy, in patients with recurrent or rese…
-
CLINICAL_TRIALS trial_result · 2026-02-18Clinical Trial Update: Study on Trabectedin in Combination With Pioglitazone in Patients Myxoid Liposarcomas With Stable Disease After T Alone. [Phase 2]
A Phase 2 trial evaluating the combination of trabectedin and pioglitazone in myxoid liposarcoma has completed.
-
CLINICAL_TRIALS trial_result · 2026-01-09Clinical Trial Update: Brightline-4: A Study to Test How Well Brigimadlin is Tolerated by People With a Type of Cancer Called Dedifferentiated Liposarcoma [Phase 3]
Phase 3 Brightline-4 trial evaluating brigimadlin tolerability in patients with dedifferentiated liposarcoma has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-11-21Clinical Trial Update: TQB3616 Capsules in the Treatment of Dedifferentiated Liposarcoma [Phase 2]
A Phase 2 trial of TQB3616 capsules for dedifferentiated liposarcoma has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-10-14Clinical Trial Update: Palbociclib and INCMGA00012 in People With Advanced Liposarcoma [Phase 2]
Phase 2 clinical trial evaluating the combination of palbociclib and INCMGA00012 in advanced well-differentiated or dedifferentiated liposar…
-
CLINICAL_TRIALS trial_result · 2025-08-28Clinical Trial Update: Study of DCC-3014 in Combination With Avelumab in Patients With Advanced or Metastatic Sarcomas [Phase 1]
Phase 1 study of DCC-3014 in combination with Avelumab in patients with advanced or metastatic sarcoma has completed; no efficacy data is pr…
-
CLINICAL_TRIALS trial_result · 2025-07-10Clinical Trial Update: Real-world Study of Dedifferentiated Liposarcoma Patients in China
This entry reports completion and posted results of a real-world observational study of dedifferentiated liposarcoma patients in China spons…
-
CLINICAL_TRIALS trial_result · 2025-07-04Clinical Trial Update: Brightline-1: A Study to Compare Brigimadlin (BI 907828) With Doxorubicin in People With a Type of Cancer Called Dedifferentiated Liposarcoma [Phase 2, Phase 3]
A Phase 2/3 trial comparing Brigimadlin (BI 907828) to doxorubicin in patients with dedifferentiated liposarcoma has completed and results h…
-
CLINICAL_TRIALS trial_result · 2025-06-05Clinical Trial Update: Study of Abemaciclib in Dedifferentiated Liposarcoma [Phase 2]
Phase 2 study of abemaciclib in dedifferentiated liposarcoma is currently active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2025-04-04Clinical Trial Update: Phase II Trial of Ribociclib and Everolimus in Advanced Dedifferentiated Liposarcoma (DDL) and Leiomyosarcoma (LMS) [Phase 2]
Phase II clinical trial evaluating ribociclib in combination with everolimus in advanced dedifferentiated liposarcoma and leiomyosarcoma; th…
-
CLINICAL_TRIALS trial_result · 2025-01-14Clinical Trial Update: Treatment of Milademetan Versus Trabectedin in Patient With Dedifferentiated Liposarcoma [Phase 3]
A Phase 3 trial comparing Milademetan to Trabectedin in dedifferentiated liposarcoma was terminated; results have been posted.
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Phase 1, First-in-human Study of Oral TP-1287 in Patients with Advanced Solid Tumors [Phase 1]
Phase 1 first-in-human study of oral TP-1287 in patients with advanced solid tumors, including specific sarcoma subtypes, has been terminate…
-
CLINICAL_TRIALS trial_result · 2021-12-07Clinical Trial Update: Selinexor in Advanced Liposarcoma [Phase 2, Phase 3]
Phase 2/3 trial of selinexor in dedifferentiated liposarcoma has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2021-09-14Clinical Trial Update: Ph II Cabazitaxel DD Liposarcoma [Phase 2]
Phase II trial update for cabazitaxel in dedifferentiated liposarcoma (completed).
-
CLINICAL_TRIALS trial_result · 2020-06-16Clinical Trial Update: Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Sarcoma That Cannot Be Removed by Surgery [Phase 2]
A Phase 2 trial evaluating nivolumab with or without ipilimumab in metastatic or unresectable sarcoma shows results from a completed study.
-
CLINICAL_TRIALS trial_result · 2019-11-12Clinical Trial Update: Efficacy and Safety of Plitidepsin in Patients With Advanced Unresectable or Metastatic, Relapsed/Refractory, Dedifferentiated Liposarcoma (DLPS): an Exploratory Phase II Multicenter Trial [Phase 2]
Exploratory Phase II multicenter trial assessing efficacy and safety of plitidepsin in advanced unresectable/metastatic dedifferentiated lip…
-
CLINICAL_TRIALS trial_result · 2017-10-25Clinical Trial Update: A Study Assessing Efficacy & Safety of Ribociclib in Patients With Advanced Well/Dedifferentiated Liposarcoma [Phase 2]
Phase 2 clinical trial evaluating the efficacy and safety of ribociclib in patients with advanced liposarcoma, including well-differentiated…